GE to supply sequencing technology for breast cancer research

09/29/2013 | Genetic Engineering & Biotechnology News

Researchers at Karolinska Institutet in Europe will use GE Healthcare's sequencing technology to detect alleles and mutations linked to metastatic breast cancer. The deal, whose terms were not disclosed, is part of GE's initiative to invest in the development of novel molecular imaging and cancer diagnostic capabilities. The company is also investing in biopharmaceutical manufacturing.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC